Todavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Historial de señales
Browse the complete record of transactions filed by Fenimore Christopher R., Director Financiero. Officer active across 1 company, notably Regeneron Pharmaceuticals, INC.. Cumulatively, 26 reports have been recorded. Breakdown: 0 buy · 7 sells. Total volume traded: €8.3m. Activity tracked since 20 August 2021. The latest transaction was disclosed on 18 August 2026 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Fenimore Christopher R.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8719 títulos@ 664,85 US$16.8% de su flujoCommon StockSEC:0001104659-21-109328:0
25 de 26 declaraciones
About Fenimore Christopher R.
Fenimore Christopher R. is Directeur Financier at Regeneron Pharmaceuticals, INC. on XNAS. He has made 24 filings in total, and in the recent filings tracked, the transactions are sales for EUR 8284645 between 2021-08-24 and 2025-12-09.